21 results on '"Khan, Hina"'
Search Results
2. The genomic, transcriptomic, and immunological profile of patients with recurrent/refractory NSCLC.
3. Durvalumab and consolidation SBRT following chemoradiation for stage III non-small cell lung cancer: A single institution pilot study.
4. Improving new cancer diagnosis education in a metropolitan cancer center.
5. Characterizing online engagement and academic impact of oncology research during the COVID-19 pandemic.
6. Acquired EGFR-resistant mutations in non–small cell lung cancer (NSCLC).
7. A pancancer analysis of impact of MDM2/MDM4 on immune checkpoint blockade (ICB).
8. Clinical characteristic and outcomes of KRAS G13 mutant non-small cell lung cancers.
9. Association of PAK4 expression with overall survival in patients with non-small cell lung cancer (NSCLC).
10. Comparing online engagement and academic impact of lung cancer research: An altmetric attention score and PlumX analysis.
11. Characterization of MET exon 14 skipping alterations (METex14) in non–small cell lung cancer (NSCLC) using whole transcriptome sequencing (WTS).
12. Concomitant infections in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study.
13. Clinical characteristics, co-mutations and outcomes of advanced non-small cell lung cancer (NSCLC) patients with KRAS mutations.
14. Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.
15. Is there a genomic fingerprint of Radon (Rn)-induced lung cancer (LC)? Comparison of genomic alterations in LC specimens from high and low Rn zones.
16. Discrepancies in PET-CT for staging bone marrow in HIV positive patients with lymphoma.
17. Genomic complexity and prognosis of renal medullary carcinoma.
18. BrUOG 387: Phase Ib investigator-initiated trial of a heat shock protein 90 inhibitor (HSP90i) combined with a CDK4/6i in advanced breast cancer progressing on CDK4/6i and in solid tumors with retinoblastoma (Rb)-deficiency (IND163592).
19. Co-mutational status and PD-L1 expression in KRAS mutant non-small cell lung cancer (NSCLC): Role in treatment selection and association with clinical outcomes.
20. Disparities in lung cancer screening in a diverse urban population and the impact of a community-based navigational program.
21. Testosterone Levels and Quality of Life in Diverse Male Patients With Cancers Unrelated to Androgens
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.